Pfizer · Operating Cash Flow (Statement)

Latest reported$13.40Bperiod endingJun 28, 2026

PFE TTM Cash from Operations ($860.50M → $13.40B)

TTM operating cash flow (statement)

High-resolution chart · PNG

PFE operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jul 1, 2001	8,983,000,000
Apr 1, 2001	6,945,000,000
Dec 31, 2000	6,195,000,000
Oct 1, 2000	4,823,000,000
Jul 2, 2000	3,864,000,000
Apr 2, 2000	4,244,000,000
Dec 31, 1999	3,056,000,000
Oct 3, 1999	3,173,000,000
Jul 4, 1999	2,817,000,000
Apr 4, 1999	2,697,000,000
Dec 31, 1998	2,929,000,000
Sep 27, 1998	2,002,000,000
Jun 28, 1998	1,678,000,000
Mar 29, 1998	1,470,000,000
Dec 31, 1997	1,629,000,000
Sep 28, 1997	1,916,000,000
Jun 29, 1997	2,021,000,000
Mar 30, 1997	2,113,000,000
Dec 31, 1996	2,067,000,000
Sep 29, 1996	1,966,800,000
Jun 30, 1996	1,795,400,000
Mar 31, 1996	1,484,600,000
Dec 31, 1995	1,821,400,000
Oct 1, 1995	1,647,800,000
Jul 2, 1995	1,634,700,000
Apr 2, 1995	1,801,000,000
Dec 31, 1994	1,488,500,000
Oct 2, 1994	1,687,400,000
Jul 3, 1994	1,604,500,000
Apr 3, 1994	1,476,800,000
Dec 31, 1993	1,263,000,000
Sep 30, 1993	936,100,000
Jun 30, 1993	873,600,000
Mar 31, 1993	814,400,000
Dec 31, 1992	807,000,000
Sep 30, 1992	821,400,000
Jun 30, 1992	734,000,000
Mar 31, 1992	794,800,000
Dec 31, 1991	847,600,000
Sep 30, 1991	883,500,000
Jun 30, 1991	840,100,000
Mar 31, 1991	825,400,000
Dec 31, 1990	860,500,000